In this study, on the basis of the potential cytoprotective effects by activating pro-survival kinases in multiple cell types, adropin was in vitro used to improve the survival potential of mesenchymal stem cells (MSCs), and meanwhile, in vivo to attenuate the inflammation in rat MI. Here, ENHO is linked to myocardial infarction.